These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2901148)

  • 1. Antagonism of bromobenzene-induced hepatotoxicity by the alpha-adrenergic blocking agents, phentolamine and idazoxan.
    Kerger BD; Gandy J; Bucci TJ; Roberts SM; Harbison RD; James RC
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):12-23. PubMed ID: 2901148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of bromobenzene-induced hepatotoxicity by the alpha-adrenoreceptor blocking agents phentolamine and idazoxan: role of hypothermia.
    Kerger BD; Roberts SM; Harbison RD; James RC
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):360-9. PubMed ID: 2564219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of bromobenzene-induced hepatotoxicity by phentolamine: evidence for a metabolism-independent intervention.
    Kerger BD; Roberts SM; Hinson JA; Gandy J; Harbison RD; James RC
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):24-31. PubMed ID: 2901149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of cocaine-induced hepatotoxicity by the alpha adrenergic antagonists phentolamine and yohimbine.
    James RC; Schiefer MA; Roberts SM; Harbison RD
    J Pharmacol Exp Ther; 1987 Aug; 242(2):726-32. PubMed ID: 2886651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the alpha-adrenoceptor antagonists phentolamine, phenoxybenzamine, and idazoxan on sympathetic blood flow control in the periodontal ligament of the cat.
    Edwall B; Gazelius B
    Acta Odontol Scand; 1988 Jun; 46(3):127-33. PubMed ID: 2900588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of hepatotoxicity.
    Roberts SM; DeMott RP; James RC
    Drug Metab Rev; 1997; 29(1-2):329-53. PubMed ID: 9187524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in man.
    Muir NC; Doxey JC; Havler ME; Clifford JM
    J Pharmacol Methods; 1987 Sep; 18(2):95-102. PubMed ID: 2887703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a cysteine prodrug, L-2-oxothiazolidine-4-carboxylic acid, on the metabolism and toxicity of bromobenzene: an acute study.
    Brodeur J; Goyal R
    Can J Physiol Pharmacol; 1987 May; 65(5):816-22. PubMed ID: 3621045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of locally applied noradrenergic agents at cerebellar Purkinje neurons: receptor specificity.
    Parfitt KD; Freedman R; Bickford-Wimer PC
    Brain Res; 1988 Oct; 462(2):242-51. PubMed ID: 2847850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver glutathione depletion induced by bromobenzene, iodobenzene, and diethylmaleate poisoning and its relation to lipid peroxidation and necrosis.
    Casini AF; Pompella A; Comporti M
    Am J Pathol; 1985 Feb; 118(2):225-37. PubMed ID: 3970139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
    Brown MJ; Harland D
    Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of the alpha 2-adrenoceptor antagonist idazoxan.
    Sanger DJ
    Psychopharmacology (Berl); 1989; 99(1):117-21. PubMed ID: 2571173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of 16,16-dimethyl prostaglandin E2 on the hepatotoxicity of bromobenzene in mice.
    Funck-Brentano C; Tinel M; Degott C; Letteron P; Babany G; Pessayre D
    Biochem Pharmacol; 1984 Jan; 33(1):89-96. PubMed ID: 6704144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of bromobenzene hepatotoxicity in the male rat by zinc.
    McMillan DA; Schnell RC
    Fundam Appl Toxicol; 1985 Apr; 5(2):297-304. PubMed ID: 3988000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of bencianol (ZY 15051) and idazoxan (RX 781094) to norepinephrine in feline pial arteries in situ.
    Wahl M; Schilling L
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):205-15. PubMed ID: 2872863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
    Harland D; Brown MJ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and haemodynamic effects of alpha 2-adrenoceptor stimulation and antagonism in man.
    Brown MJ; Struthers AD; Di Silvio L; Yeo T; Ghatei M; Burrin JM
    Clin Sci (Lond); 1985; 68 Suppl 10():137s-139s. PubMed ID: 2857610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
    Angel I; Niddam R; Langer SZ
    J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.
    Ostenson CG; Pigon J; Doxey JC; Efendic S
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1054-9. PubMed ID: 2903169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.